New Treatments for Migraines: What Actually Works in 2025? Introduction Migraine affects approximately 10% of the global population, including 25% of adult women and 9% of children. It ranks as the third leading cause of years lived with disability, according to the 2019 Global Burden of Disease
Tag: CGRP monoclonal antibodies
